Introduction
============

Macroautophagy (hereafter, autophagy) is a highly conserved degradation pathway in which cellular constituents are sequestered by a double-membrane vesicle called the autophagosome and delivered to the lysosome (in mammalian cells) or the vacuole (in yeast and plant cells; [@bib32]; [@bib52]; [@bib27]). Autophagy can occur in both nonselective and selective manners. Under starvation conditions, the autophagosome randomly sequesters a portion of the cytoplasm, and the degradation products are supplied as essential nutrient sources. On the other hand, when deleterious materials, such as protein aggregates, damaged mitochondria, or invasive bacteria arise within cells, the autophagosome enwraps them exclusively for elimination. These latter types of autophagy, termed selective autophagy, have attracted attention in recent years as a result of their direct relevance to human diseases ([@bib6]; [@bib13]; [@bib26]; [@bib49]).

Studies in yeast have identified ∼40 autophagy-related (Atg) proteins, among which 15 proteins play fundamental roles in the formation of the autophagosomal membrane in any type of autophagy and are thus considered to be the core machinery. Some of the other Atg proteins regulate the core machinery and determine the targets of autophagosomal sequestration in selective autophagy. In the budding yeast *Saccharomyces cerevisiae*, the cytoplasm-to-vacuole targeting (Cvt) pathway is a selective autophagy--related pathway that mediates the transport of enzymes that function in the vacuolar lumen ([@bib24]). Although the Cvt pathway is in essence a biosynthetic pathway, studies of this pathway have established the conceptual framework of target recognition during selective autophagy. In the Cvt pathway, the vacuolar aminopeptidase Ape1 self-assembles in the cytoplasm to form an aggregate-like structure that is recognized by the receptor protein Atg19 ([Fig. 1 A](#fig1){ref-type="fig"}; [@bib17]; [@bib42]). Atg19 also binds other vacuolar enzymes such as the aspartyl aminopeptidase Ape4 and the α-mannosidase Ams1, thereby incorporating them into the assembly ([@bib10]; [@bib44]; [@bib53]). Atg19 then recruits the adaptor protein Atg11, which associates the assembly with the vacuolar membrane and recruits the core Atg proteins to initiate membrane formation ([@bib44]).

![**Hrr25 is involved in the Cvt pathway.** (A) Schematic model for the initiation of the Cvt pathway (see Introduction for details). (B) Yeast cells grown to mid--log phase (OD~600~ = ∼2) were treated with or without IAA for 30 min and examined by immunoblotting using anti-AID and anti-GFP antibodies. Pgk1 served as a loading control. (C) Cells grown to an OD~600~ of ∼1.0 were treated with or without IAA. The values of OD~600~ at each time point were plotted to draw the growth curve. The data shown are from a single representative experiment out of multiple experiments performed under similar conditions. (D, left) Cells expressing Ams1-GFP were grown to late log phase (OD~600~ = ∼4), treated with or without IAA for 2 h, and examined by immunoblotting using antibodies against Ape1 and GFP. GFP′ indicates GFP fragments produced by the vacuolar cleavage of Ams1-GFP. (right) The intensities of the bands corresponding to pApe1 and mApe1 were measured, and the ratios of mApe1 to total Ape1 are shown as the efficiencies of Ape1 maturation (percentages). Error bars represent standard deviations (*n* = 3). (E) Cells grown to mid--log phase were treated with or without IAA, further grown to post--log phase (OD~600~ = ∼6.0), and examined by immunoblotting using antibodies against Ape1. (F) Cells grown to mid--log phase were treated with IAA for 30 min. Ape1 maturation at the indicated time periods after the addition of 50 µg/ml cycloheximide was examined by immunoblotting using anti-Ape1 antibodies. WT, wild type.](JCB_201402128_Fig1){#fig1}

Mitophagy and pexophagy are selective-autophagy pathways that target mitochondria and peroxisomes, respectively, and recent studies identified Atg32 and Atg36 as specific receptors for these pathways in *S*. *cerevisiae* ([@bib15]; [@bib37]; [@bib28]). Both mitophagy and pexophagy use Atg11 as an adaptor; as with Atg19 in the Cvt pathway, Atg32 and Atg36 interact with Atg11 to trigger the corresponding pathways. In light of the increasing number of other examples, it is now generally accepted that autophagic receptors recruit the core Atg proteins to the appropriate targets, either via adaptors or directly, to initiate most selective autophagy pathways in organisms ranging from yeast to humans ([@bib18]; [@bib13]; [@bib49]; [@bib47]).

Under normal conditions, most of the protein and organelle targets of selective autophagy play essential roles in various cellular activities. Therefore, regulation of the initiation of their sequestration is critical; however, the mechanisms underlying these regulatory events remain elusive. In mitophagy and pexophagy, expression levels of Atg32 and Atg36 are increased under conditions that induce the corresponding pathway ([@bib37]; [@bib28]). This may be an aspect of the mechanism that regulates initiation of these pathways. However, the forced expression of the receptors under noninducing conditions does not lead to degradation of the target organelles significantly ([@bib15]; [@bib37]; [@bib28]). This observation implied the existence of additional regulatory mechanisms that activate these pathways under appropriate conditions. Indeed, Atg32 and Atg36 are phosphorylated under mitophagy- and pexophagy-inducing conditions, respectively ([@bib2]; [@bib28]). It was proposed that the phosphorylation of these receptors is important for the induction of each pathway, but the responsible kinases have remained unknown.

Hrr25 is a homologue of CK1δ (casein kinase 1δ) that phosphorylates Ser or Thr residues in proteins and is involved in a wide range of cellular functions, including the DNA damage response, chromosome segregation, ribosome biogenesis, and membrane traffic ([@bib9]; [@bib5]; [@bib39]; [@bib41]; [@bib23]). Here, we show that Hrr25 phosphorylates Atg19 and Atg36 to initiate the Cvt pathway and pexophagy, respectively, by promoting their interactions with Atg11.

Results
=======

Hrr25 is required for the Cvt pathway but not for starvation-induced autophagy
------------------------------------------------------------------------------

A global analysis of yeast kinase interactions indicated that Hrr25 interacts with Cvt pathway--related proteins, including Atg19 and Atg11 ([@bib4]). Therefore, we investigated whether Hrr25 is involved in the Cvt pathway. Because Hrr25 is essential for yeast growth, we used the auxin-inducible degron (AID) system to conditionally knock down its expression. In this system, a protein fused with the AID tag is rapidly degraded by the ubiquitin--proteasome system, when cells are treated with the plant hormone auxin ([@bib34]). Hrr25 was efficiently knocked down when cells expressing C-terminally AID-tagged Hrr25 (*hrr25-aid* cells) were treated with the auxin indole-3-acetic acid (IAA; [Fig. 1 B](#fig1){ref-type="fig"}). Under these conditions, the cells continued to grow at a slower rate ([Fig. 1 C](#fig1){ref-type="fig"}), which should be supported by a residual amount of the protein ([Fig. 1 B](#fig1){ref-type="fig"}). Using this strain, we examined the involvement of Hrr25 in the Cvt pathway. In wild-type cells, vacuolar transport of Ape1 via the Cvt pathway results in the removal of the propeptide from Ape1: specifically, Ape1 is converted from the proform (pApe1) to the mature form (mApe1) in the vacuole ([Fig. 1 D](#fig1){ref-type="fig"}). In cells lacking Atg19, Ape1 maturation was completely blocked, as reported previously ([@bib42]). We found that *hrr25-aid* cells treated with IAA showed a remarkable defect in the maturation of Ape1 ([Fig. 1 D](#fig1){ref-type="fig"}). A milder but significant defect was also observed in *hrr25-aid* cells without IAA treatment, indicating that AID tagging itself affects the function of Hrr25 to some extent. Whereas we analyzed cells grown to late log phase in these experiments, the Cvt pathway is more active in later stages of growth; a larger proportion of Ape1 was matured in wild-type cells in post--log phase ([Fig. 1 E](#fig1){ref-type="fig"}; also see the following paragraph). We showed that a severe defect was also observed in Hrr25-depleted cells in this growth phase. In addition, we performed cycloheximide chase experiments to examine the kinetics of Ape1 maturation ([Fig. 1 F](#fig1){ref-type="fig"}). Most pApe1 was converted to the mature form during the chase period in wild-type cells, but this conversion was significantly retarded in Hrr25-depleted cells. We also monitored the vacuolar transport of another Cvt target, Ams1, by detecting GFP fragments generated by the cleavage of Ams1-GFP in the vacuole ([Fig. 1 D](#fig1){ref-type="fig"}). The results showed that depletion of Hrr25 also severely impaired vacuolar transport of Ams1. These results suggested that Hrr25 is required for the Cvt pathway.

We also examined the involvement of Hrr25 in starvation-induced autophagy. First, we observed the vacuolar transport of GFP-Atg8 ([@bib48]; [@bib43]). Because Atg8 is transported into the vacuole via autophagy, GFP fluorescence in the vacuole increases in wild-type cells expressing GFP-Atg8 upon treatment with the autophagy-inducer rapamycin ([Fig. 2 A](#fig2){ref-type="fig"}). When the core Atg protein Atg2 was knocked down using the AID system, the vacuolar transport of GFP-Atg8 was strongly blocked. In contrast, knockdown of Hrr25 did not affect vacuolar transport of Atg8. The vacuolar cleavage of GFP-Atg8 results in the production of GFP fragments (GFP′), which are detected by immunoblotting using anti-GFP antibodies ([Fig. 2, B and C](#fig2){ref-type="fig"}; and [Fig. S1, A and B](http://www.jcb.org/cgi/content/full/jcb.201402128/DC1){#supp1}). In agreement with the results of fluorescence microscopy, no significant decrease in the production of GFP fragments was observed in *hrr25-aid* cells treated with IAA, although Hrr25 was also efficiently knocked down in the presence of rapamycin. We also performed an alkaline phosphatase (ALP) assay to assess autophagic activity of cells (i.e., bulk degradation of the cytoplasm; [@bib36]). Whereas knockdown of Atg2 significantly reduced autophagic activity induced by nitrogen starvation or rapamycin treatment, that of Hrr25 had no effect ([Figs. 2 D](#fig2){ref-type="fig"} and S1 C). These results suggest that Hrr25 is not required for starvation-induced, nonselective autophagy.

![**Starvation-induced, nonselective autophagy normally occurs in Hrr25-depleted cells.** (A) Cells expressing GFP-Atg8 were treated with rapamycin (rap) in the presence or absence of IAA for 3 h followed by fluorescence microscopy. Arrowheads indicate vacuoles. BF, bright field. Bars, 5 µm. (B) Cells used in A were also examined by immunoblotting using antibodies against GFP and AID. GFP′ indicates GFP fragments produced by the vacuolar degradation of GFP-Atg8. (C) The intensities of the bands in B were quantified, and GFP′ intensity was divided by the sum of GFP′ and GFP-Atg8 intensities to calculate processed GFP (percentages). Error bars represent standard deviations (*n* = 3). (D) Cells expressing Pho8Δ60 were incubated in nitrogen starvation medium in the presence or absence of IAA for the indicated time periods, and ALP activities in cell lysates were measured. The values for wild-type cells starved for 4 h in the absence of IAA were set as 100. Error bars represent standard deviations (*n* = 3). AU, arbitrary unit; WT, wild type.](JCB_201402128_Fig2){#fig2}

Nitrogen starvation and rapamycin treatment promote vacuolar transport of Ape1, which largely depends on Atg19 and Atg11 as well as that under normal conditions (i.e., the Cvt pathway). We showed that Hrr25 is also important for Ape1 transport in cells treated with rapamycin (Fig. S1 D).

Hrr25 promotes Atg11 targeting to the Ape1--Atg19 complex
---------------------------------------------------------

We next sought to determine which step in the Cvt pathway ([Fig. 1 A](#fig1){ref-type="fig"}) was affected by Hrr25 depletion. The self-assembly of Ape1 can be observed under a fluorescence microscope as the formation of dots of mRFP-Ape1; this process was not affected by the knockdown of Hrr25 ([Fig. 3 A](#fig3){ref-type="fig"}). In wild-type cells, the receptor protein Atg19 localizes to Ape1 dots, and this step was also unaffected by Hrr25 knockdown ([Fig. 3 A](#fig3){ref-type="fig"}). In the following step, the adaptor protein Atg11 is recruited to the Ape1--Atg19 complex and thus colocalizes with Ape1 dots in wild-type cells ([Fig. 3 B](#fig3){ref-type="fig"}). In Hrr25-depleted cells, this step was significantly impaired, and Atg11 was dispersed throughout the cytoplasm.

![**Hrr25 promotes Atg11 targeting to the Ape1--Atg19 complex by strengthening the Atg19--Atg11 interaction.** (A and B) Yeast cells coexpressing mRFP-Ape1 and either Atg19-GFP (A) or Atg11-GFP (B) were treated with or without IAA for 2 h and observed under a fluorescence microscope. Ape1 dots colocalized with Atg19 or Atg11 were counted, and their percentages relative to the total numbers of Ape1 dots are shown with standard deviations (*n* = 3). BF, bright field. Bars, 5 µm. (C) Cells expressing Atg19-GFP and Atg11-3×HA were treated with or without IAA for 2 h. The cell lysates (total) were subjected to immunoprecipitation using the anti-GFP antibody, and the immunoprecipitates (IP) were analyzed by immunoblotting using antibodies against Atg19, HA, and Ape1. Open arrowheads indicate phosphorylated Atg19. WT, wild type.](JCB_201402128_Fig3){#fig3}

The recruitment of Atg11 is a prerequisite for the recruitment of core Atg proteins, such as Atg1 and Atg8, and as expected, the localization of these proteins to Ape1 dots was also compromised in Hrr25-depleted cells ([Fig. S2, A--C](http://www.jcb.org/cgi/content/full/jcb.201402128/DC1){#supp2}). A previous study reported that the Ape1--Atg19 complex is detached from the vacuole in the absence of Atg11 ([@bib44]). Consistent with that finding, knockdown of Hrr25 caused detachment of Ape1 dots from the vacuole, similar to the situation in *atg11*Δ cells, although it did not affect the total amount of Atg11 (Fig. S2, D and E). Collectively, these data suggested that Hrr25 depletion impairs Atg11 targeting to the Ape1--Atg19 complex, resulting in the impairment of the Cvt pathway.

Hrr25 phosphorylates the COP II component Sec23 to regulate vesicle traffic from the ER to the Golgi ([@bib23]), and both the Cvt pathway and starvation-induced autophagy are defective in *sec23* mutant cells ([@bib11]). Therefore, we investigated whether the depletion of Hrr25 indirectly affected the Cvt pathway via a defect in Sec23 function. To this end, we knocked down Sec23 using the AID system and confirmed that both the Cvt pathway and starvation-induced autophagy were impaired in Sec23-depleted cells ([Fig. S3, A and B](http://www.jcb.org/cgi/content/full/jcb.201402128/DC1){#supp3}). However, in contrast to the situation in Hrr25 knockdown cells, Atg11-GFP substantially localized to mRFP-Ape1 dots in Sec23 knockdown cells (Fig. S3 C). Thus, defective Atg11 targeting to the Ape1--Atg19 complex in Hrr25-depleted cells cannot be attributed to compromised Sec23 function.

Hrr25-mediated Atg19 phosphorylation promotes the Atg19--Atg11 interaction
--------------------------------------------------------------------------

Because Atg11 recruitment to the Ape1--Atg19 complex is mediated by the direct interaction between Atg19 and Atg11 ([@bib44]), we next asked whether the knockdown of Hrr25 would affect this interaction. Immunoprecipitation of Atg19 coprecipitated Atg11 as well as pApe1 in wild-type cells ([Fig. 3 C](#fig3){ref-type="fig"}). Hrr25 knockdown markedly reduced the coprecipitation of Atg11 without affecting that of pApe1, suggesting that Hrr25 is required for the Atg19--Atg11 interaction. In these experiments, additional bands were observed above the major bands of both wild-type Atg19 and Atg19-GFP in wild-type cells but not in *hrr25-aid* cells treated with IAA ([Fig. 3 C](#fig3){ref-type="fig"}). These additional bands disappeared when the immunoprecipitates were treated with protein phosphatase ([Fig. 4 A](#fig4){ref-type="fig"}), suggesting that they represented phosphorylated forms of Atg19 and that Hrr25 is involved in Atg19 phosphorylation. We expressed GST-fused Atg19 and Hrr25 in *Escherichia coli* and subjected the purified proteins to an in vitro kinase assay. Recombinant Hrr25 phosphorylated GST-Atg19 but not GST alone ([Fig. 4 B](#fig4){ref-type="fig"}). In addition, the phosphorylation of GST-Atg19 was not observed when the kinase-dead mutant of Hrr25 (K38A; [@bib9]; [@bib29]) was used. Collectively, these results suggest that Hrr25 directly phosphorylates Atg19 in the Cvt pathway.

![**Hrr25-mediated phosphorylation in the Atg11-binding region of Atg19 promotes the Atg19--Atg11 interaction.** (A) Immunoprecipitates obtained from yeast cells expressing Atg19-GFP using anti-GFP antibody were treated with λ protein phosphatase in the presence or absence of phosphatase inhibitors and analyzed by immunoblotting using anti-Atg19 antibodies. (B) Recombinant GST and GST-Atg19 were incubated with wild-type Hrr25 (WT) or the K38A mutant (KA) in the presence of ATP and visualized by immunoblotting using anti-GST antibody. Protein phosphorylation was detected using the phosphate-binding reagent Phos-tag. The asterisk indicates a nonspecific band that appeared independently of Hrr25 activity in the Phos-tag staining. (C) The amino acid sequence of the Atg11-binding region in Atg19. Ser and Thr residues are colored blue. (D) Ape1 maturation in *atg19*Δ cells carrying single-copy Atg19 plasmids or the empty vector was monitored as described in [Fig. 1 D](#fig1){ref-type="fig"}. (E) *ATG11-3×HA atg19*Δ cells carrying single-copy Atg19-GFP plasmids were subjected to immunoprecipitation (IP) as described in [Fig. 3 C](#fig3){ref-type="fig"}. (F and G) *mRFP-APE1 atg19*Δ cells carrying single-copy Atg19-GFP plasmids (F) or *Atg11-GFP mRFP-APE1 atg19*Δ cells carrying single-copy Atg19 plasmids (G) were observed under a fluorescence microscope. Bars, 5 µm. (H) *hrr25-aid atg1*Δ *atg19*Δ cells expressing Atg19 mutants from single-copy plasmids were treated with or without IAA for 2 h, and Atg19 phosphorylation was analyzed by SDS-PAGE using the Anderson gel system and immunoblotting using anti-Atg19 antibodies. Open arrowheads indicate phosphorylated Atg19. (I) In vitro kinase assay was performed using GST-Atg19 mutants and wild-type Hrr25 as described in B; the reaction mixtures were incubated for 30 min. (J) In vitro kinase assay was performed using GST-Atg11 and wild-type Hrr25 as described in B. WT, wild type.](JCB_201402128_Fig4){#fig4}

We further investigated Hrr25-mediated phosphorylation sites on Atg19. A previous study showed that deletion of eight residues in the C-terminal region of Atg19 (amino acids 388--395) abolishes its binding to Atg11, indicating that Atg19 interacts with Atg11 via this region ([Fig. 4 C](#fig4){ref-type="fig"}; [@bib44]). We hypothesized that Hrr25 phosphorylates a Ser or Thr residue in this region and that this modification increases the affinity of Atg19 for Atg11. Ser and Thr residues in this region were replaced with Ala individually, and the maturation of Ape1 in cells expressing these Atg19 mutants was examined ([Fig. 4 D](#fig4){ref-type="fig"}). We found that the S391A and S394A mutations caused the severe defect in Ape1 maturation. Immunoprecipitation analysis showed that both of these mutants were defective in the interaction with Atg11 ([Fig. 4 E](#fig4){ref-type="fig"}). Consistent with these results, localization of Atg11 to Ape1 dots was significantly decreased in both of the mutants, although the mutant proteins themselves efficiently localized to Ape1 dots ([Fig. 4, F and G](#fig4){ref-type="fig"}). To analyze the phosphorylation state of the nontagged Atg19 mutants, we used the Anderson gel system ([@bib1]), which allowed the clear separation of their phosphorylated and unphosphorylated forms ([Fig. 4 H](#fig4){ref-type="fig"}). Both Ser391 and Ser394 are within the motif for phosphorylation by CK1 ([@bib51]). However, the S391A mutation, but not S394A, attenuated the Hrr25-dependent phosphorylation of Atg19. The phosphorylation state of the S391A S394A double mutant (S391/S394A) was similar to that of the S391A single mutant. In addition, an in vitro kinase assay showed that Hrr25 phosphorylated the S391A mutant to a lesser degree, whereas the S394A mutant was phosphorylated comparably to the wild-type protein ([Fig. 4 I](#fig4){ref-type="fig"}). Introducing the S394A mutation did not decrease the phosphorylation level of the S391A mutant. Collectively, these data suggest that Hrr25 phosphorylates Ser391 in the Atg11-binding region of Atg19, thereby increasing its affinity for Atg11 and promoting Atg11 targeting to the Ape1--Atg19 complex. Ser394 is important for the Atg19--Atg11 interaction but may not be phosphorylated. It should be noted that Hrr25-dependent phosphorylation was still observed in the S391A mutant ([Fig. 4, H and I](#fig4){ref-type="fig"}), suggesting that Hrr25 also phosphorylates other residues of Atg19 in addition to Ser391.

Because a previous mass spectrometric analysis identified not only Atg19 but also Atg11 in immunoprecipitates of Hrr25 ([@bib4]), we examined the possibility that Hrr25 phosphorylates Atg11. In the immunoblotting analysis of yeast cell lysates, a band shift that might represent Atg11 phosphorylation was not observed ([Fig. 3 C](#fig3){ref-type="fig"}). In addition, an in vitro analysis showed that Hrr25 scarcely phosphorylated GST-Atg11 in contrast to GST-Atg19 ([Fig. 4 J](#fig4){ref-type="fig"}). These results suggest that Hrr25 does not phosphorylate Atg11. Our immunoblotting analysis of the immunoprecipitate of Hrr25 detected Atg19 but not Atg11 ([Fig. S4](http://www.jcb.org/cgi/content/full/jcb.201402128/DC1){#supp4}). Atg11 indirectly bound to Hrr25 via Atg19 might be identified in the previous analysis.

Atg19 phosphorylation by Hrr25 activates the Cvt pathway in late growth phases
------------------------------------------------------------------------------

The Cvt pathway has often been described as constitutively active. However, in fact, the mature form of Ape1 increases as the culture approaches the end of logarithmic growth ([Figs. 5 A](#fig5){ref-type="fig"} and [1 C](#fig1){ref-type="fig"}). We also performed cycloheximide chase experiments to examine the kinetics of the vacuolar transport of Ape1 in cells in different growth phases ([Fig. 5 B](#fig5){ref-type="fig"}). When wild-type cells were grown to later phases, the expression level of pApe1 increased, and the amount of pApe1 converted to mApe1 during the chase period also increased ([Fig. 5 B](#fig5){ref-type="fig"}, right graph). Although the initial amount of pApe1 (at time 0) in early log phase (OD~600~ = ∼1) was lower than that in late log phase (OD~600~ = ∼4), its conversion to mApe1 was not significantly faster than that in the latter phase ([Fig. 5 B](#fig5){ref-type="fig"}, left graph). These results suggest that Ape1 transport activity is enhanced in later stages of growth in wild-type cells. Knockdown of Hrr25 severely retarded Ape1 transport in all the growth phases ([Fig. 5 B](#fig5){ref-type="fig"}). We also showed that Atg19 phosphorylation increased in a manner similar to the stimulation of Ape1 transport ([Fig. 5 A](#fig5){ref-type="fig"}). Phosphorylated Atg19 accumulated more evidently when the Cvt pathway was blocked by *ATG1* deletion, consistent with the notion that phosphorylated Atg19 is an active form, which is preferentially incorporated into the Cvt vesicle and degraded in the vacuole. The expression of Atg19 increased as cells were grown to later phases ([Fig. 5 A](#fig5){ref-type="fig"}). This obscured whether Atg19 phosphorylation by Hrr25 is constitutive or regulated. To solve this problem, we replaced the promoter of *ATG19* on the chromosome with that of the constitutively expressing gene *CET1*. In this strain, the level of Atg19 was almost constant among different growth phases, and the up-regulation of Hrr25-dependent Atg19 phosphorylation in later growth phases was clearly observed ([Fig. 5 C](#fig5){ref-type="fig"}). Collectively, these results suggest that Hrr25 is required for the basal activity of the Cvt pathway and also up-regulates the pathway as yeast cell culture proceeds to later growth phases (also see Discussion).

![**Hrr25 activates the Cvt pathway in late growth phases via Atg19 phosphorylation.** (A, left) Yeast cells were grown to different OD~600~ and subjected to immunoblotting using antibodies against Ape1, Atg19, and Pgk1. A sample prepared from Hrr25-depleted cells (Hrr25 knockdown \[KD\]) served to distinguish between phosphorylated and unphosphorylated Atg19. (middle and right) The intensities of the bands corresponding to pApe1, mApe1, and phosphorylated (open arrowheads) and unphosphorylated (closed arrowheads) Atg19 were measured, and the efficiencies of Ape1 maturation (percentages) and Atg19 phosphorylation (percentages) are shown with error bars (standard deviations; *n* = 3). (B) Cells grown to the indicated OD~600~ were treated with 50 µg/ml cycloheximide, and Ape1 maturation at different time points was examined by immunoblotting using anti-Ape1 antibodies. The ratios of mApe1 to total Ape1 (percentages) at each time point were shown with error bars representing standard deviations (*n* = 3). The amounts of Ape1 transported into the vacuole during the chase period were also estimated as follows. The mApe1/total Ape1 ratios at time 0 were set as 0 by subtracting the intensities of mApe1 at time 0 as background. Then, these values were multiplied by the intensities of pApe1 at time 0, and the values for wild-type cells grown to an OD~600~ of ∼1 were set as 100. Error bars represent standard deviations (*n* = 3). AU, arbitrary unit. (C) Yeast cells were grown to different OD~600~ and subjected to immunoblotting using antibodies against GFP and Pgk1. *hrr25-aid* cells in mid--log phase were treated with IAA and grown to an OD~600~ of ∼8 to prepare the Hrr25 knockdown sample. (D) Yeast cells were grown to mid--log phase and shifted to a nitrogen starvation (nitro. starv.) medium containing IAA. WT, wild type.](JCB_201402128_Fig5){#fig5}

Using yeast cells constitutively expressing Atg19, we showed that the phosphorylation of Atg19 by Hrr25 was also promoted by nitrogen starvation ([Fig. 5 D](#fig5){ref-type="fig"}). Hrr25 was important for vacuolar transport of Ape1 in the presence of rapamycin that mimics nitrogen starvation (Fig. S1 D). Hrr25 may also contribute to the stimulation of Ape1 transport under starvation conditions by phosphorylating Atg19.

Hrr25 is required for pexophagy
-------------------------------

We investigated whether Hrr25 is involved in other selective-autophagy pathways. The cytoplasmic aldehyde dehydrogenase Ald6 is preferentially degraded via autophagy under nitrogen starvation conditions ([@bib38]). We assessed autophagic degradation of Ald6 by detecting GFP fragments generated from Ald6-GFP in the vacuole; the results showed that Hrr25 is not required for this pathway ([Fig. S5 A](http://www.jcb.org/cgi/content/full/jcb.201402128/DC1){#supp5}). We also examined ribophagy, autophagic degradation of ribosomes under starvation conditions, by monitoring vacuolar processing of GFP-fused ribosomal proteins ([@bib20]); knockdown of Hrr25 had no effect on ribophagy (Fig. S5 B). We next examined the involvement of Hrr25 in mitophagy. To this end, we used two different constructs, the mitochondrial matrix protein Idh1 fused with GFP ([@bib14]) and mitochondrial matrix-targeted dihydrofolate reductase (mtDHFR)--mCherry ([@bib19]). The vacuolar processing of these proteins was examined under mitophagy-inducing conditions. The results suggested that Hrr25 is not important for mitophagy (Fig. S5, C and D). We also showed that the mitophagy-specific receptor Atg32 fused with GST was only slightly phosphorylated by Hrr25 in contrast to GST-Atg19 in an in vitro kinase assay (Fig. S5 E). Finally, we examined pexophagy under Hrr25-depleted conditions. Yeast cells expressing the peroxisomal protein Pex11 fused with GFP were cultured in an oleate medium to cause proliferation of peroxisomes and then shifted to a glucose medium without a nitrogen source to induce pexophagy ([@bib28]). GFP fragments resulting from the vacuolar degradation of Pex11-GFP accumulated in wild-type cells but not in mutant cells lacking the pexophagy receptor Atg36, and knockdown of Hrr25 almost completely blocked Pex11-GFP degradation ([Fig. 6 A](#fig6){ref-type="fig"}). As in the case of the Cvt pathway, *hrr25-aid* cells exhibited a significant defect in pexophagy even in the absence of IAA treatment ([Figs. 1 D](#fig1){ref-type="fig"} and [6 A](#fig6){ref-type="fig"}). Pexophagy is also induced by prolonged culture of yeast cells in an oleate medium ([@bib28]). *hrr25-aid* cells not treated with IAA exhibited a severe defect in pexophagy under this alternative condition ([Fig. 6 B](#fig6){ref-type="fig"}). These results suggest that Hrr25 is necessary not only for the Cvt pathway but also for pexophagy.

![**Hrr25 is required for pexophagy and responsible for Atg36 phosphorylation.** (A, left) Yeast cells expressing Pex11-GFP were grown in an oleate medium and then incubated in nitrogen starvation (nitro. starv.) medium in the presence or absence of IAA and examined by immunoblotting using anti-GFP antibodies. GFP′, GFP fragments produced by the vacuolar degradation of Pex11-GFP. (right) GFP′ intensity was divided by the sum of GFP′ and Pex11-GFP intensities to calculate Pex11-GFP degradation (deg.; percentages). Error bars represent standard deviations (*n* = 3). (B) Cells expressing Pex11-GFP were grown in an oleate medium without IAA for the indicated time periods, and pexophagy was examined by immunoblotting using anti-GFP antibodies. (C) Cells expressing Atg36-GFP were incubated for 2 h under pexophagy-inducing conditions as described in A in the presence of IAA and subjected to immunoprecipitation using anti-GFP antibody. The immunoprecipitates were treated with λ protein phosphatase in the presence or absence of phosphatase inhibitors and analyzed by immunoblotting using anti-GFP antibodies. (C--E) The square brackets indicate phosphorylated Atg36-GFP (C and D) or GST-Atg36 (E). (D) Cells were incubated under pexophagy-inducing conditions as described in A and analyzed by immunoblotting with antibodies against GFP, AID, and Pgk1. (E) In vitro kinase assay was performed using GST-Atg36 as described in [Fig. 4 B](#fig4){ref-type="fig"}. The asterisk indicates a nonspecific band that appeared in the Phos-tag staining independently of Hrr25 activity. (F) Yeast cells were grown to different OD~600~ and analyzed by immunoblotting as described in [Fig. 5 C](#fig5){ref-type="fig"}. (G) Yeast cells were grown to mid--log phase and shifted to a nitrogen starvation medium containing IAA. (F and G) Open arrowheads indicate phosphorylated Atg36-GFP. KD, knockdown; WT, wild type.](JCB_201402128_Fig6){#fig6}

Hrr25 is responsible for Atg36 phosphorylation
----------------------------------------------

Atg36 is phosphorylated by an unknown kinase under pexophagy-inducing conditions ([@bib28]). In light of our finding that Hrr25 is a kinase required for pexophagy, we investigated the possibility that Hrr25 phosphorylates Atg36. To test this idea, we used cells lacking Atg1 to block Atg36 degradation via pexophagy. As reported previously, Atg36-GFP was detected as multiple bands under pexophagy-inducing conditions, which were downshifted to a single band by phosphatase treatment, suggesting that these bands represented phosphorylated Atg36 ([Fig. 6 C](#fig6){ref-type="fig"}; [@bib28]). Phosphorylation of Atg36 was markedly decreased by the depletion of Hrr25 ([Fig. 6, C and D](#fig6){ref-type="fig"}). Moreover, an in vitro kinase assay revealed that Hrr25 directly phosphorylates Atg36 ([Fig. 6 E](#fig6){ref-type="fig"}). Collectively, these results suggest that Hrr25 phosphorylates Atg36 during pexophagy.

A previous study reported that the phosphorylation of Atg36 was promoted when yeast cells were subjected to nitrogen starvation after successive culture in a glucose medium and an oleate medium, during which expression of Atg36 increased and its phosphorylation also occurred to some extent ([@bib28]). To more clearly investigate conditions that stimulate Atg36 phosphorylation, we constructed yeast cells that constitutively expressed Atg36 under the control of the *CET1* promoter. We found that Hrr25-dependent phosphorylation of Atg36 was suppressed in the cells grown to mid--log phase (OD~600~ = ∼2) in a glucose medium and remarkably induced in later growth phases ([Fig. 6 F](#fig6){ref-type="fig"}). We also showed that Atg36 phosphorylation by Hrr25 was stimulated when the cells grown to mid--log phase in a glucose medium were directly subjected to nitrogen starvation without culture in an oleate medium ([Fig. 6 G](#fig6){ref-type="fig"}). These results suggest that as in the case of Atg19 ([Fig. 5, C and D](#fig5){ref-type="fig"}), Hrr25-dependent Atg36 phosphorylation is stimulated in late growth phases and under nitrogen starvation conditions.

Hrr25 controls Atg11 targeting to Atg36 on the peroxisome
---------------------------------------------------------

Atg36 is anchored to the peroxisome by its association with the peroxisomal protein Pex3 and also interacts with Atg11 for its recruitment ([@bib28]). Because this molecular mechanism is analogous to that of the Cvt pathway, we hypothesized that Hrr25-mediated phosphorylation of Atg36 promotes its interaction with Atg11. Indeed, immunoprecipitation analysis showed that knockdown of Hrr25 weakened the interaction of Atg36 with Atg11, whereas it did not affect its interaction with Pex3 ([Fig. 7, A and B](#fig7){ref-type="fig"}). Consistent with these results, Atg11 failed to localize to the peroxisome in Hrr25-depleted cells, although Atg36 localized normally to the peroxisome ([Fig. 7, C and D](#fig7){ref-type="fig"}). These results suggest that Hrr25 promotes Atg11 targeting to the peroxisome by strengthening the Atg36--Atg11 interaction.

![**Hrr25 targets Atg11 to the peroxisome by promoting the Atg36--Atg11 interaction.** (A and B) *atg1*Δ (Hrr25 knockdown \[KD\], −) and *hrr25-aid atg1*Δ cells (Hrr25 knockdown, +) coexpressing Atg11-3×HA (A) or Pex3-9×Myc (B) with Atg36-GFP or Atg36 fused with the tandem affinity purification (TAP) tag were incubated under pexophagy-inducing conditions in the presence of IAA for 2 h as described in [Fig. 6 A](#fig6){ref-type="fig"}. The cell lysates (total) were subjected to immunoprecipitation using anti-GFP antibody, and the immunoprecipitates (IP) were analyzed by immunoblotting using antibodies against GFP, HA, and Myc. Atg36-TAP was detected using HRP-conjugated anti--mouse IgG. (C and D) Cells coexpressing Pex11-mCherry and either Atg36-GFP (C) or Atg11-GFP and Atg36-ECFP (see Materials and methods; D) were treated with IAA for 2 h under pexophagy-inducing conditions and observed under a fluorescence microscope. Pex11 dots colocalized with Atg36 or Atg11 were counted, and their percentages relative to the total numbers of Pex11 dots are shown with standard deviations (*n* = 3). White and black arrowheads indicate Pex11 dots with and without clear Atg11 signals, respectively. Bars, 5 µm. BF, bright field.](JCB_201402128_Fig7){#fig7}

Analysis of Atg36 residue phosphorylated by Hrr25
-------------------------------------------------

It appears that Atg36 is phosphorylated at multiple residues and that Hrr25 is responsible for most of these modifications ([Fig. 6 D](#fig6){ref-type="fig"}). We sought to determine a phosphorylation site in Atg36 involved in pexophagy regulation by Hrr25. A recent study proposed a consensus sequence for Atg11 binding (D/SILSSS) in Atg32, Atg36, and PpAtg30 (a pexophagy receptor in the methylotrophic yeast *Pichia pastoris*; [@bib8]), and this motif is also found in Atg19 ([Fig. 8 A](#fig8){ref-type="fig"}). It is remarkable that Ser391 of Atg19 ([Fig. 4](#fig4){ref-type="fig"}), Ser114 of Atg32, and Ser112 of PpAtg30 ([@bib7]; [@bib2]), whose phosphorylation is important for the interaction of these receptors with Atg11, are all located within the motif. Moreover, it was shown that a mutation at Ser97 of Atg36, which is at the same position as the phosphorylated Ser residues in Atg32 and PpAtg30, caused severe defects in the Atg36--Atg11 interaction and pexophagy ([Fig. 8, B and C](#fig8){ref-type="fig"}; [@bib8]). We further showed that Atg11 was barely recruited to peroxisomes in the Atg36 mutant ([Fig. 8, D and E](#fig8){ref-type="fig"}). Moreover, Atg36 phosphorylation was partially but significantly decreased by the S97A mutation ([Fig. 8 F](#fig8){ref-type="fig"}). We also examined the phosphorylation of this mutant in vitro. Because Hrr25 intensely phosphorylated Atg36 in vitro, we used a truncated form of Atg36 (Asp91-Gln147), in which background phosphorylation was eliminated ([Fig. 8 G](#fig8){ref-type="fig"}). When this form of Atg36 was incubated with Hrr25, its phosphorylation was detected as a single band with a slower mobility on SDS-PAGE, and this phosphorylation was totally abolished by the S97A mutation. Collectively, these results suggest that Ser97 is one of the Atg36 residues phosphorylated by Hrr25, which is important for the Atg36--Atg11 interaction and thus for pexophagy.

![**Analysis of the Atg36 S97A mutant.** (A) Amino acid sequences of Atg11-binding regions in autophagic receptors. Ser and Thr residues are colored blue. Arrowheads indicate experimentally determined or predicted phosphorylation sites. (B) *ATG11-3×HA atg1*Δ *atg36*Δ cells carrying single-copy Atg36-GFP plasmids or the empty vector were subjected to immunoprecipitation (IP) as described in [Fig. 7 A](#fig7){ref-type="fig"}. (C) Pexophagy in *PEX11-GFP atg36*Δ cells carrying single-copy Atg36-3×FLAG plasmids or the empty vector was examined as described in [Fig. 6 A](#fig6){ref-type="fig"}. nitro. starv., nitrogen starvation; GFP′, GFP fragments produced by the vacuolar degradation of Pex11-GFP. (D) *PEX11-mCherry atg1*Δ *atg36*Δ cells carrying single-copy Atg36-GFP plasmids were subjected to pexophagy-inducing conditions for 2 h and observed under a fluorescence microscope. Bars, 5 µm. (E) *ATG11-GFP PEX11-mCherry atg1*Δ *atg36*Δ cells expressing wild-type Atg36 or the S97A mutant fused with a nonfluorescent mutant of GFP (see Materials and methods) from single-copy plasmids were analyzed as described in D. White and black arrowheads indicate Pex11 dots with and without clear Atg11 signals, respectively. Bars, 5 µm. (F) *atg1*Δ *atg36*Δ cells carrying single-copy Atg36-GFP plasmids or the empty vector were incubated under pexophagy-inducing conditions for 2 h and examined by immunoblotting using antibodies against GFP and Pgk1. The square bracket indicates phosphorylated Atg36-GFP. (G) In vitro kinase assay was performed using 3 µM GST-Atg36 (91--147) variants and 0.1 µM wild-type Hrr25 as described in [Fig. 4 B](#fig4){ref-type="fig"}. White and black arrowheads indicate phosphorylated and unphosphorylated GST-Atg36 (91--147), respectively. WT, wild type.](JCB_201402128R_Fig8){#fig8}

Discussion
==========

In this study, we investigated the role of Hrr25 in selective autophagy. We first showed that Hrr25 phosphorylates Atg19 to regulate the initiation of Cvt vesicle formation. Our results suggest that Atg19 phosphorylation by Hrr25 is required for both the basal activity of the Cvt pathway and its stimulation in late growth phases. The expression of pApe1 and Atg19 is induced under those growth conditions ([Fig. 5](#fig5){ref-type="fig"}). This is also likely to enhance the Cvt pathway, the contribution of which may be represented as the difference in the Ape1 transport activity of Hrr25-depleted cells in early and late log phases ([Fig. 5 B](#fig5){ref-type="fig"}, right graph, open and closed triangles). However, the degree was much smaller than the contribution of Hrr25, which may be represented as the difference between wild-type and Hrr25-depleted cells in late log phase ([Fig. 5 B](#fig5){ref-type="fig"}, right graph, closed circles and triangles). These results suggest that Hrr25-mediated Atg19 phosphorylation plays a predominant role in the stimulation of the Cvt pathway in late growth phases. The active transport of degradative enzymes via the Cvt pathway would increase vacuolar degradation capacity and therefore be important for cells to adapt to environmental changes under those growth conditions.

We also showed that Hrr25 is a kinase responsible for the phosphorylation of the pexophagy receptor Atg36. The finding that the same kinase regulates two distinct selective autophagy--related pathways was unexpected. However, both the Cvt pathway and pexophagy are activated under similar conditions, including growth-saturating and nitrogen starvation conditions. A common signal triggered by both of these conditions may stimulate Hrr25 to phosphorylate Atg19 and Atg36. Pexophagy, which disposes of superfluous peroxisomes, is strongly induced under the aforementioned conditions after culture in a peroxisome-proliferating medium, in which the expression of Atg36 is elevated. In contrast, pexophagy occurs only moderately under normal growth conditions even if Atg36 is forcibly expressed ([@bib28]). Therefore, an appropriate combination of multiple distinct signals that induce Atg36 expression and promote its phosphorylation by Hrr25 may be required for initiation of pexophagy.

Hrr25-mediated phosphorylation of Atg19 and Atg36 increased the interactions of both of these receptors with the adaptor Atg11. Thus, Hrr25 regulates the Cvt pathway and pexophagy by a uniform mechanism ([Fig. 9](#fig9){ref-type="fig"}). During the course of this study, another group has reported similar results showing the involvement of Hrr25 in the Cvt pathway ([@bib40]). Phosphorylation of several Atg19 residues, including Ser391, was detected by mass spectrometry. It was also suggested that Hrr25 phosphorylates some of these residues to promote the Atg19--Atg11 interaction. In addition, it has recently been reported that the mitophagy receptor Atg32 is phosphorylated by casein kinase 2, which allows Atg32 to interact with Atg11 ([@bib16]). Moreover, it was shown that PpAtg30 is also phosphorylated, and this phosphorylation is important for the binding of PpAtg30 to Atg11 ([@bib8]). Although the kinase that phosphorylates PpAtg30 is still unknown, these observations suggest that the initiation of these selective autophagy--related pathways is regulated by conceptually identical mechanisms, i.e., phosphoregulation of the receptor--adaptor interaction.

![**Model for the regulation of selective autophagy--related pathways by Hrr25.** Hrr25 regulates the initiation of the Cvt pathway and pexophagy by conceptually identical mechanisms. Hrr25 phosphorylates Atg19 and Atg36 (R, receptor), which, respectively, recognize the assembly of vacuolar enzymes and the peroxisome (target), to recruit Atg11 (A, adaptor), which subsequently recruits the core Atg proteins that mediate membrane formation. P, phosphorylated.](JCB_201402128_Fig9){#fig9}

Phosphorylation of receptors can also regulate their interactions with degradation targets ([@bib25]) or core Atg proteins ([@bib50]; [@bib22]; [@bib8]). Furthermore, a recent study has provided the case that methylation of Arg residues in degradation targets promotes their interactions with an adaptor ([@bib21]). Thus, the initiation of selective autophagy is regulated at multiple steps by different protein modifications. This indicates the significance of the regulation of selective autophagy, for which other types of mechanisms may also operate in cells.

Hrr25 is a CK1δ homologue that plays pivotal roles in a variety of cellular events, some of which are conserved across species. This study revealed a new role for this kinase, the regulation of selective autophagy, raising a series of related questions: Are CK1δ homologues also involved in selective autophagy in other organisms? How does Hrr25/CK1δ regulate diverse cellular processes under different conditions? What is the relationship between selective autophagy and other cellular processes that are regulated by Hrr25/CK1δ? Future studies should address these important issues.

Materials and methods
=====================

Yeast strains
-------------

The yeast strains used in this study are listed in [Table S1](http://www.jcb.org/cgi/content/full/jcb.201402128/DC1){#supp6}. Gene disruption and tagging were performed by a PCR-based method ([@bib12]; [@bib33]). The strains for the AID-based depletion of proteins ([@bib34]) were similarly constructed by adding the AID tag sequence to the C termini of Hrr25 and Atg2 or the N terminus of Sec23. The strains expressing mRFP-Ape1 were constructed by integrating pPS128 (donated by D. Klionsky, University of Michigan, Ann Arbor, MI), which expresses the fusion protein from the *APE1* promoter ([@bib46]), into the *APE1* locus on the chromosome. Peroxisomes form a few clusters in a cell when Atg36 is C-terminally tagged with GFP ([@bib28]; also seen in [Fig. 7 C](#fig7){ref-type="fig"}); otherwise, they are dispersed in the cytoplasm as multiple dots. Because Atg11 also forms a considerable number of dots under pexophagy-inducing conditions, it was difficult to assess whether their colocalization was significant in cells expressing Atg11-GFP and Pex11-mCherry. Therefore, ECFP was fused to the C terminus of Atg36 in those cells to allow examination of Atg11 localization to the peroxisome ([Fig. 7 D](#fig7){ref-type="fig"}). As a result of the same reason, the plasmids expressing Atg36 fused with a nonfluorescent mutant of GFP were used in [Fig. 8 E](#fig8){ref-type="fig"} to observe the peroxisomal localization of Atg11-GFP in the Atg36 S97A mutant.

Plasmids
--------

The plasmids to express the Atg19 mutants in yeast (used in [Fig. 4](#fig4){ref-type="fig"}) were constructed as follows. Oligonucleotide sequences used in this study are given in [Table S2](http://www.jcb.org/cgi/content/full/jcb.201402128/DC1){#supp7}. The *ATG19* gene with its own promoter and terminator regions was amplified by PCR from BY4741 ([@bib3]) genomic DNA using the primers XhoI-ATG19-forward and ATG19-BamHI-reverse and ligated into the single-copy vector pRS313 ([@bib45]) using appropriate restriction enzymes. Similarly, the *ATG19-GFP* and *ATG36-GFP* genes with their own promoters were amplified by PCR using genomic DNA from CTY275 and YNH803 and the pairs of oligonucleotides XhoI-ATG19-forward and PGKter-SacI-reverse and KpnI-ATG36-forward and PGKter-SacI-reverse to construct pRS313-*ATG19-GFP* (used in [Fig. 4](#fig4){ref-type="fig"}) and pRS316-*ATG36-GFP*. A DNA region containing the *ATG36-GFP* gene in pRS316-*ATG36-GFP* was subcloned into pRS315 using PvuII to construct pRS315-*ATG36-GFP* (used in [Fig. 8](#fig8){ref-type="fig"}). To construct the plasmids for expression of GST-fused proteins in *E. coli*, the open reading frames of *ATG36* and *HRR25* were amplified by PCR from BY4741 genomic DNA using the primers BamHI-ATG36-forward and ATG36-SalI-reverse or BamHI-HRR25-forward and HRR25-SalI-reverse and ligated into the pGEX-6P-1 vector (GE Healthcare) using appropriate restriction enzymes. pGEX-6P-*ATG36* (*Asp91-Gln147*) and that containing the S97A mutation were similarly constructed using the primers BamHI-ATG36-91-forward/BamHI-ATG36-91-S97A-forward and ATG36-147-SalI-reverse. pGEX-6P-*ATG19* ([@bib35]), pGEX-6P-*ATG11* (donated by N. Noda, Institute of Microbial Chemistry, Tokyo, Japan), and pGEX-6P-*ATG32 (2--388)* (donated by K. Okamoto, Osaka University, Osaka, Japan) were used to express GST-fused Atg19, Atg11, and Atg32 (2--388) in *E. coli*, respectively. Site-directed mutagenesis was performed using the QuikChange kit (Agilent Technologies), and appropriate pairs of oligonucleotides were used to construct the Atg19, Atg36, and Hrr25 mutant plasmids. pRS315-*ATG36-3×FLAG* and pRS315-*ATG36--nonfluorescent GFP* (used in [Fig. 8 E](#fig8){ref-type="fig"}) were also constructed by site-directed mutagenesis using pRS315-*ATG36-GFP* as a template and the pairs of oligonucleotides Atg36-GFP\>3×FLAG-forward and Atg36-GFP\>3×FLAG-reverse and GFP-inactivation-forward and GFP-inactivation-reverse, respectively.

Media
-----

Yeast cells were cultured in synthetic dextrose (SD) + casamino acids (CA) + ATU medium (0.17% yeast nitrogen base \[YNB\] without amino acids and ammonium sulfate \[YNB w/o aa and as\], 0.5% ammonium sulfate, 2% glucose, 0.5% CA, 0.002% adenine sulfate, 0.002% tryptophan, and 0.002% uracil) at 30°C, except that cells carrying pRS313- and pRS315-derived plasmids were cultured in SD + dropout medium (0.17% YNB w/o aa and as, 0.5% ammonium sulfate, and 2% glucose supplemented with 0.002% adenine sulfate, 0.002% uracil, and appropriate amino acids) lacking histidine and leucine, respectively. To induce nonselective autophagy, cells were treated with 0.2 µg/ml rapamycin or incubated in nitrogen starvation medium SD-N (0.17% YNB w/o aa and as and 2% glucose). Pexophagy was induced as described previously ([@bib28]). In brief, yeast cultures grown in SD + CA + ATU or SD + dropout medium for 24 h were diluted 10-fold with SO + CA + ATU medium (0.17% YNB w/o aa and as, 0.5% ammonium sulfate, 0.12% oleate, 0.2% Tween 40, 0.1% glucose, 1% CA, 0.1% yeast extract, 0.002% adenine sulfate, 0.002% tryptophan, and 0.002% uracil) and grown for 18 h, and the medium was replaced with SD-N. For auxin treatment, IAA was added to a final concentration of 0.5 mM, and the same volume of solvent ethanol was added to control samples ([@bib34]).

Immunoblotting
--------------

Yeast cell pellets (∼1.5--6.0 OD units) were suspended in 200 µl of 20% trichloroacetic acid, kept on ice for 15 min, and centrifuged at 15,000 *g* for 5 min. The pellets were washed with 1 ml of cold acetone, dried at room temperature, and suspended in (OD units × 50) µl of SDS sample buffer by mixing at 65°C for 10 min followed by cell disruption at room temperature using FastPrep-24 (MP Biomedicals) and 0.5-mm YZB zirconia beads (Yasui Kikai). These samples were boiled for 3 min and centrifuged at 15,000 *g* for 1 min; the supernatants were used for immunoblotting analysis ([@bib30]). To separate phosphorylated and unphosphorylated forms of nontagged Atg19, the Anderson gel system (10% acrylamide and bis-acrylamide at 77:1) was used ([@bib1]). Monoclonal antibodies against GFP (11814460001; Roche), AID (BioROIS), GST (B-14; Santa Cruz Biotechnology, Inc.), HA (3F10; Roche), and Myc (9E10; Santa Cruz Biotechnology, Inc.) sequences were used for detection of tagged proteins. The monoclonal antibody against Pgk1 was purchased from Invitrogen. The phosphate-binding reagent Biotinylated Phos-tag (Wako Pure Chemical Industries) was used to detect protein phosphorylation in combination with streptavidin-HRP (Invitrogen).

Microscopic image acquisition
-----------------------------

Fluorescence microscopy was performed using an inverted fluorescence microscopy system (IX71; Olympus) equipped with a 150× objective lens (U Apochromat N 150×, NA 1.45; Olympus), a charge-coupled device camera (ImagEM Enhanced; Hamamatsu Photonics), blue (Sapphire 488--20; Coherent) and yellow lasers (85-YCA-010; Melles Griot), and band pass filters (FF495-Em02-25 and FF593-Em02-25; Semrock) for visualization of GFP and mCherry, respectively. Images were acquired using Aquacosmos software (Hamamatsu Photonics) and processed using MetaMorph 7.0r4 (Molecular Devices) and Photoshop CS6 (Adobe). The images were not manipulated other than contrast and brightness adjustments.

ALP assay
---------

To quantify autophagic activity of yeast cells, an ALP assay was performed ([@bib36]). In brief, yeast cells expressing a cytoplasm-localized mutant of vacuolar ALP (Pho8Δ60) were incubated under autophagy-inducing conditions, in which Pho8Δ60, as a part of the cytoplasm, was delivered into the vacuole via autophagy and activated by a vacuolar processing enzyme. The activity in cell lysates was measured using a fluorogenic substrate.

Immunoprecipitation
-------------------

To examine the interaction between Atg19 and Atg11, yeast cells expressing Atg19-GFP and Atg11-3×HA were disrupted in buffer A (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 10% glycerol) containing 2 mM PMSF and 2× protease inhibitor cocktail (Complete, EDTA-free; Roche) using a Multi-beads Shocker (Yasui Kikai) and 0.5-mm YZB zirconia beads. Nonidet P-40 was added to the lysates to a final concentration of 0.01%, and the samples were rotated at 4°C for 30 min. The solubilized lysates were cleared by centrifugation at 15,000 *g* for 5 min, mixed with GFP-Trap_M beads (ChromoTek), and rotated at 4°C for 2 h. The beads were washed with buffer A, and the bound proteins were eluted by incubating the beads in SDS sample buffer at 65°C for 5 min. To examine the Atg36--Atg11 and Atg36--Pex3 interactions, cells expressing Atg36-GFP and either Atg11-3×HA or Pex3-9×Myc were spheroplasted by incubation in SD-N containing 1.2 M sorbitol, 0.1 M Tris-HCl, pH 8.0, and 0.2 mg/ml Zymolyase 100T (Seikagaku Biobusiness) at 30°C for 1 h, washed with buffer A containing 5 mM EDTA, 5 mM EGTA, 50 mM NaF, and 2 mM PMSF, and lysed in the same buffer additionally containing 2× protease inhibitor cocktail, 1× phosphatase inhibitor cocktail (PhosSTOP; Roche), 500 nM microcystin, and 0.5% (vol/vol) Triton X-100. The lysates were cleared by centrifugation and subjected to immunoprecipitation with GFP-Trap_M beads.

Phosphatase treatment
---------------------

Cell lysates were prepared and incubated with GFP-Trap_M beads, as described in the previous paragraph. The beads were washed with buffer A and incubated with λ protein phosphatase (New England Biolabs, Inc.) at 30°C for 1 h under the recommended conditions in the presence or absence of 5× Halt phosphatase inhibitor cocktail (Thermo Fisher Scientific).

Protein purification
--------------------

*E. coli* Rosetta cells carrying pGEX-6P-Atg19, -Atg11, -Atg32 (2--388), -Atg36, -Hrr25, and -Hrr25 K38A or the pGEX-6P-1 vector (for GST purification) were cultured in Luria broth medium (10 mg/ml tryptone, 5 mg/ml yeast extract, 10 mg/ml NaCl, and 1 mM NaOH) containing 50 µg/ml ampicillin and 50 µg/ml chloramphenicol at 37°C to an OD~600~ of ∼0.5, and protein expression was induced in the presence of 0.1 mM isopropyl β-D-thiogalactopyranoside at 16°C for 24 h. Cells were harvested and disrupted in buffer B (20 mM Hepes-KOH, pH 7.2, and 150 mM NaCl) containing 5 mM DTT, 0.5 mM EDTA, and 0.1 mM PMSF as described previously ([@bib31]). The cleared lysates were rotated with glutathione--Sepharose 4B resin (GE Healthcare) at 4°C for 45 min. The resins were washed with buffer B, and bound proteins were eluted with 50 mM Tris-HCl, pH 8.0, containing 150 mM NaCl and 10 mM reduced glutathione. The GST-Hrr25--bound resins were treated with the PreScission Protease (GE Healthcare), which cleaves the recognition sequence between the GST and Hrr25 moieties, to elute Hrr25. The purified proteins were appropriately concentrated using Vivaspin columns (Sartorius) and stored at −80°C in solutions containing 25% glycerol.

In vitro kinase assay
---------------------

0.3 µM GST, GST-Atg19, GST-Atg11, or GST-Atg36 was incubated at 30°C with 0.05 µM wild-type Hrr25 or Hrr25 K38A in 20 mM Hepes-KOH, pH 7.2, containing 150 mM NaCl, 1 mM MgCl~2~, 0.2 mM DTT, and 1 mM ATP.

Online supplemental material
----------------------------

Fig. S1 shows nonselective autophagy in Hrr25-depleted cells. Fig. S2 shows the localization of Atg proteins and Ape1 in Hrr25-depleted cells. Fig. S3 shows Atg11 localization in Sec23-depleted cells. Fig. S4 shows immunoprecipitation analysis of Hrr25. Fig. S5 shows selective autophagy of Ald6, ribosomes, and mitochondria in Hrr25-depleted cells. Table S1 lists yeast strains used in this study. Table S2 lists oligonucleotides used in this study. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201402128/DC1>.
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